# Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

> **NCT00003596** · PHASE3 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 682 (actual)

## Conditions studied

- Anal Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **DRUG:** mitomycin C
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003596
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-10
- **Primary completion:** 2005-10
- **Final completion:** 2016-12
- **Target enrollment:** 682 (ACTUAL)
- **Last updated:** 2017-01-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003596, "Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*